You have 9 free searches left this month | for more free features.

sflt-1

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pathogenesis and Severity of COVID-19 Disease

Recruiting
  • COVID-19 Disease
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Nov 8, 2022

    Pre-Eclampsia Trial in Nice (sFlt-1/PlGF ratio)

    Not yet recruiting
    • Pre-Eclampsia
    • sFlt-1/PlGF ratio
    • Nice, France
      Nice University Hospital
    Jan 27, 2022

    Intrauterine Growth Restriction, Fetal Growth Restriction (FGR) Trial in Colombes (Blood test at time of inclusion for

    Recruiting
    • Intrauterine Growth Restriction
    • Fetal Growth Restriction (FGR)
    • Blood test at time of inclusion for sFlt-1/PlGF ratio
    • +2 more
    • Colombes, France
      Hôpital Louis Mourier
    Nov 25, 2021

    Preeclampsia Trial in Paris (sFlt-1 / PlGF ratio)

    Completed
    • Preeclampsia
    • sFlt-1 / PlGF ratio
    • Paris, France
      CHU Cochin, Maternité Port Royal
    Jul 31, 2021

    Complications of Placental Vascular Pathologies in 3rd Quarter

    Completed
    • Pre-Eclampsia
    • +5 more
    • sampling of the serum marker sFlt1 and PlGF
    • Chambéry, Savoie, France
    • +6 more
    Jun 13, 2022

    COVID-19 Trial in Monza (Hematolgy and Chemistry analysis, Real Time PCR, PROS assay COVID+)

    Recruiting
    • COVID-19
    • Hematolgy and Chemistry analysis
    • +5 more
    • Monza, Lombardia, Italy
      San Gerardo Hospital
    Apr 27, 2022

    Biomarkers and Preeclampsia Outcomes

    Completed
    • Preeclampsia
      • Tunis, Tunisia
        Maternity Center of Tunis
      Aug 19, 2022

      Preeclampsia, Intrauterine Growth Restriction, Maternal Hypertension Trial in Worldwide (sFlt1/PlGF screening in maternal blood

      Recruiting
      • Preeclampsia
      • +4 more
      • sFlt1/PlGF screening in maternal blood at 35 to 37 weeks of gestation
      • Liège, Belgium
      • +13 more
      Mar 14, 2022

      Preeclampsia Trial in Paris (A collection of maternal plasma and serum)

      Completed
      • Preeclampsia
      • A collection of maternal plasma and serum
      • Paris, France
        Hopital Cochin
      Sep 22, 2021

      Gestational Diabetes, Gestational Hypertension, Pre-Eclampsia Trial in Pisa

      Recruiting
      • Gestational Diabetes
      • +2 more
        • Pisa, PI, Italy
          Azienda Ospedaliero-Universitaria Pisana - U.O. Malattie Metabol
        May 5, 2021

        Organ Dysfunction in Critically-ill Patients With COVID-19?

        Completed
        • CORONAVIRUS INFECTIONS
        • measurement of circulating sFlt1 concentration
        • Reims, France
          Chu Reims
        Mar 31, 2021

        Soluble Factors and Renal Outcome in Preeclampsia

        Completed
        • Preeclampsia
        • Renal Function
        • Renal function
        • proteinuria
        • Bangkok, Thailand
          Faculty of Medicine,Vajira Hospital
        Jun 24, 2021

        sFlt- 1, PIGF, and Niacin Levels in Premature Ovarian

        Completed
        • Premature Ovarian Insufficiency
        • ultrasound assessment
        • Gaziantep, Turkey
          Cengiz Gokcek Women's and Child's hospital
        Aug 30, 2021

        Screening of Preeclampsia and Intrauterine Growth Restriction

        Completed
        • Preeclampsia
        • Intrauterine Growth Restriction
        • Ultrasound study of the placenta
        • Measurement of angiogenic and anti-angiogenic factors (sFlt-1 and PlGF) in the first trimestre blood test
        • Barcelona, Spain
          Hospital de la Santa Creu i Sant Pau
        Mar 8, 2022

        sFlt-1:PlGF Ratio in Diagnosing Superimposed Preeclampsia

        Completed
        • Preeclampsia
          • Memphis, Tennessee
            Regional One Health Center for High Risk Pregnancies
          Nov 11, 2020

          Fetal Growth Retardation, Preeclampsia, Placenta Diseases Trial in Spain (soluble fms-like tyrosine kinase to placental growth

          Not yet recruiting
          • Fetal Growth Retardation
          • +2 more
          • soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF)
          • A Coruña, Spain
          • +23 more
          Mar 17, 2022

          Fetal Growth Retardation Trial in Spain (Management based on sFlt-1/PlGF values)

          Recruiting
          • Fetal Growth Retardation
          • Management based on sFlt-1/PlGF values
          • A Coruña, Spain
          • +19 more
          Dec 20, 2021

          Interest of sFlt1/PlGF Ratio at Obstetric Emergencies

          Unknown status
          • Suspected Placental Dysfunction, Ruled Out
          • +2 more
          • Diagnostic test
          • Créteil, France
            Centre Hospitalier Intercommunal de Créteil
          Dec 12, 2019

          Patients Pregnant or Without Primary Antiphospholipid Antibody

          Recruiting
          • Preeclampsia
          • +5 more
          • Collection of epidemiological and anamnestic data and collection of biological material (peripheral blood)
          • Milan, Italy
            San Raffaele Hospital
          Mar 28, 2023

          Preeclampsia Postpartum Trial (Aspirin 81Mg Ec Tab)

          Not yet recruiting
          • Preeclampsia Postpartum
          • Aspirin 81Mg Ec Tab
          • (no location specified)
          Jun 21, 2023

          Cut-offs to Improve Stratification

          Active, not recruiting
          • Preeclampsia and Eclampsia
          • +5 more
            • Los Angeles, California
            • +17 more
            Mar 7, 2022

            Preeclampsia Trial in Barcelona (Placental biomarkers)

            Unknown status
            • Preeclampsia
            • Placental biomarkers
            • Barcelona, Spain
              Hospital de la Santa Creu i Sant Pau
            Oct 22, 2019

            Pre-Eclampsia Trial in Barcelona (ASA-withdrawn group)

            Completed
            • Pre-Eclampsia
            • ASA-withdrawn group
            • Barcelona, Spain
              Hospital Universitari Vall d'Hebron
            Feb 15, 2022

            Preeclampsia Severe, Preeclampsia Second Trimester, Preterm Birth Complication Trial in Newark (Esomeprazole 20mg)

            Not yet recruiting
            • Preeclampsia Severe
            • +2 more
            • Esomeprazole 20mg
            • Newark, Delaware
              Christiana Care Health Systems
            Nov 2, 2022

            Gestational Hypertension Trial (Angiogenic factor)

            Not yet recruiting
            • Gestational Hypertension
            • Angiogenic factor
            • (no location specified)
            Nov 2, 2023